团体标准
T/HENANPA011 -2023
医疗机构钙通道阻滞剂类药品
评价指标体系
Evaluation indicators system of calcium channel blockers in medical institutions
2023-08-11 发布 2023-08-18 实施
河南省药学会 发布
全国团体标准信息平台
全国团体标准信息平台
I
目 次
目 次 ............................................................................................................................................................... I
前 言 ............................................................................................................................................................ III
引 言 ............................................................................................................................................................ IV
医疗机构钙通道阻滞剂类药品评价指标体系 ........................................................................................... 5
1. 范围 ...................................................................................................................................... 5
2. 规范性引用文件 .................................................................................................................. 5
3. 术语和定义 .......................................................................................................................... 5
3.1 药品 Drug.......................................................................................................... 5
3.2 医疗机构 Medical Institution ........................................................................... 5
3.3 指标 Indicator ................................................................................................... 6
3.4 指标体系 Indicator System ............................................................................... 6
3.5 钙通道阻滞剂 Calcium Channel Blocker......................................................... 6
3.6 钙通道阻滞剂类药品评价指标 Indicator of Calcium Channel Blocker ......... 6
3.7 钙通道阻滞剂类药品评价指标体系 Indicator System of Calcium Channel
Blocker .............................................................................................................................. 6
3.8 一级评价指标 First Grade Assessment Indicator ............................................. 6
3.9 二级评价指标 Second Grade Assessment Indicator ........................................ 6
3.10 三级评价指标 Third Grade Assessment Indicator ......................................... 6
3.11 指标权重 Indicator Weight ............................................................................. 6
3.12 安全性评价 Safety Evaluation ....................................................................... 6
3.13 有效性评价 Validity Evaluation ..................................................................... 6
3.14 经济性评价 Economic Evaluation ................................................................. 7
3.15 创新性评价 Innovation Evaluation ................................................................ 7
3.16 适宜性评价 Suitability Evaluation ................................................................. 7
3.17 可及性评价 Accessibility Evaluation ............................................................. 7
4. 评价指标体系 ...................................................................................................................... 7
4.1 安全性评价 ........................................................................................................ 7
4.2 有效性评价 ........................................................................................................ 8
4.3 经济性评价 ........................................................................................................ 8
4.4 适宜性评价 ........................................................................................................ 8
全国团体标准信息平台
II
4.5 创新性评价 ........................................................................................................ 9
4.6 可及性评价 ........................................................................................................ 9
5. 评价
T-HENANPA 011—2023 医疗机构钙通道阻滞剂类药品评价指标体系
文档预览
中文文档
22 页
50 下载
1000 浏览
0 评论
0 收藏
3.0分
温馨提示:本文档共22页,可预览 3 页,如浏览全部内容或当前文档出现乱码,可开通会员下载原始文档
本文档由 思安 于 2023-08-26 23:40:20上传分享